Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $233.29 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chiesi USA, Inc. | $130.28 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $59.66 | 4 | $0 (2019) |
| CSL Behring | $27.32 | 2 | $0 (2018) |
| BTG International, Inc. | $16.03 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.52 | 1 | Chiesi USA, Inc. ($18.52) |
| 2023 | $61.60 | 3 | Chiesi USA, Inc. ($61.60) |
| 2022 | $35.89 | 2 | Chiesi USA, Inc. ($35.89) |
| 2019 | $89.96 | 6 | Janssen Pharmaceuticals, Inc ($59.66) |
| 2018 | $14.81 | 1 | CSL Behring ($14.81) |
| 2017 | $12.51 | 1 | CSL Behring ($12.51) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/14/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $23.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/01/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2019 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ANTI-VENOM | ||||||
| 10/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2019 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/03/2018 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/26/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 885 | 911 | $1.4M | $113,079 |
| 2022 | 4 | 825 | 853 | $1.4M | $112,573 |
| 2021 | 4 | 897 | 922 | $1.5M | $120,271 |
| 2020 | 5 | 1,050 | 1,103 | $1.8M | $144,922 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 492 | 509 | $863,385 | $68,448 | 7.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 229 | 236 | $247,584 | $21,647 | 8.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 118 | 120 | $282,589 | $19,527 | 6.9% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 17 | 17 | $17,325 | $1,870 | 10.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 29 | 29 | $19,227 | $1,588 | 8.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 528 | 550 | $928,400 | $78,250 | 8.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 99 | 102 | $241,026 | $17,729 | 7.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 134 | 136 | $143,208 | $12,929 | 9.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 64 | 65 | $42,510 | $3,664 | 8.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 567 | 589 | $994,232 | $83,262 | 8.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 100 | 103 | $243,389 | $17,766 | 7.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 160 | 160 | $168,480 | $15,188 | 9.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 70 | 70 | $45,780 | $4,055 | 8.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 707 | 755 | $1.3M | $104,809 | 8.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 111 | 113 | $266,403 | $20,030 | 7.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 158 | 159 | $167,153 | $14,953 | 8.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 58 | 59 | $38,416 | $3,086 | 8.0% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 16 | 17 | $17,106 | $2,045 | 12.0% |
About Dr. William Elliott, MD
Dr. William Elliott, MD is a Emergency Medicine healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649379199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Elliott, MD has received a total of $233.29 in payments from pharmaceutical and medical device companies, with $18.52 received in 2024. These payments were reported across 14 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($233.29).
As a Medicare-enrolled provider, Elliott has provided services to 3,657 Medicare beneficiaries, totaling 3,789 services with total Medicare billing of $490,845. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Metairie, LA
- Active Since 09/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1649379199
Products in Payments
- CLEVIPREX (Drug) $130.28
- XARELTO (Drug) $59.66
- Kcentra (Biological) $27.32
- CROFAB (Drug) $16.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Metairie
Dr. Patrick Bonneval, M.d, M.D
Emergency Medicine — Payments: $781.76
Mr. Travis Hill, Md, MD
Emergency Medicine — Payments: $688.71
Dr. Jamie Broussard, Md, MD
Emergency Medicine — Payments: $514.01
Dr. Samir Khalaf, M.d, M.D
Emergency Medicine — Payments: $246.10
Dr. Terrell Caffery, Md, MD
Emergency Medicine — Payments: $192.24
Dr. Ricky Swaim, Md, MD
Emergency Medicine — Payments: $171.45